Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment

- J. Liu

- T. Chen

- Y. Zhao

2. Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis

- Xieer Liang

- Rong Fan

- Jian Sun

- Javed Shaikh

- Ankush Taneja

- Subhajit Gupta

- Kamal Hamed

3. Adverse effects of oral antiviral therapy in chronic hepatitis B

- Bircan Kayaaslan

- Rahmet Guner

4. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

- Chia-Chi Wang

- Chih-Lin Lin

- Tsai-Yuan Hsieh

- Kuo-Chih Tseng

- Cheng-Yuan Peng

- Tung-Hung Su

- Sheng-Shun Yang

- Yu-Chun Hsu

- Tsung-Ming Chen

- Jia-Horng Kao

5. Approved Antiviral Drugs over the Past 50 Years

- Erik De Clercq

- Guangdi Li

6. Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare

- Jinfeng Liu

- Jing Wang

- Caijing Qi

- Furong Cao

- Zhen Tian

- Dandan Guo

- Taotao Yan

- Qian Li

- Shujuan Yang

- JianJun Fu

- Xianmei Tang

- Xiaoni Kou

- Na Liu

- Zicheng Jiang

- Yingren Zhao

- Tianyan Chen

7. Review: Approved Heterocycles Based Antiviral Drugs

- Adinath. D. Badar

- Pramod. S. Phatak

8. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels

- Jing‐Ya Yan

- Zhi‐Qin Li

- Zu‐Jiang Yu

- Quan‐Chen Kan

9. Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs

- Yi Shen

- Yulong Jia

- Jie Zhou

- Juling Ji

- Pengcheng Xun

10. IRMPD action spectroscopy, ER-CID experiments, and theoretical approaches investigate intrinsic L-thymidine properties compared to D-thymidine: Findings support robust methodology

- Erik O. Soley

- Zachary J. Devereaux

- L.A. Hamlow

- G. Berden

- J. Oomens

- M.T. Rodgers

11. Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification

- Jong Won Choi

- Se Hyun Kim

- Jeong Hun Seo

- Yong Suk Cho

- Sun Young Won

- Byung Kyu Park

- Han Ho Jeon

- Yong Kang Lee

- Chun Kyon Lee

12. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model

- Jia‐Horng Kao

- Tarik Asselah

- Xiao‐Guang Dou

- Kamal Hamed

13. Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment

- Xia Tang

- Wenxun Huang

- Juan Kang

- Keyue Ding